Drug-related dyslipidemia after renal transplantation-Reference-Cited by-同舟云学术

Drug-related dyslipidemia after renal transplantation

Published:2004-03-15 Issue:6 Volume:61 Page:565-585
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Scott Mathis A.¹,Davé Nisha²,Knipp Gregory T.³,Friedman Gary S.⁴

Affiliation:

1. Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey (SUNJ), Piscataway, and Clinical Specialist, Pharmacy Department, Saint Barnabas Medical Center, Livingston, NJ

2. Pharmaceutical Industry Fellowship Institute

3. Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, SUNJ

4. Physicians in Kidney Diseases and Cell Therapies, West Orange, NJ

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/61/6/565/28420012/ajhp0565.pdf

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of cyclosporin A in the treatment of kidney disease and nephrotoxicity;Toxicology;2023-06

2. Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study;Journal of Clinical Medicine;2023-03-22

3. Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial;Kidney Medicine;2023-01

4. Assessment of Renal Transplant Perfusion by Contrast-Enhanced Ultrasound after Switch from Calcineurin Inhibitor to Belatacept: A Pilot Study;Journal of Clinical Medicine;2022-07-27

5. Belatacept Conversion in Kidney After Liver Transplantation;Transplantation Direct;2021-10-22